Company Information

  

Address: 4242 CAMPUS POINT COURT, SUITE 500  
City: SAN DIEGO 
State: CA 
Zip Code: 92121 
Telephone: (858) 412-8400 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly-applicable product candidates designed to activate a patient's immune system against their own cancer. Our cancer-selective gene therapy platform is built on Retroviral Replicating Vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Our gene therapy approach is designed to fight cancer through immunotherapeutic mechanisms of action without the autoimmune toxicities commonly experienced with other immunotherapies. Our founding vision is "No One Should Die Of Cancer" because we believe the immune system can be safely activated to fight the patient's cancer.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2019-2.45NAN/E
03/2019-2.53NAN/E
12/2018-2.44NAN/E
09/2018-1.94NAN/E
06/2018-2.16NAN/E
03/20180.80NA14.81
12/2017-2.66NAN/E
09/20178.77NA1.42

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity-0.18Total Liab/Total Assets0.44
Net Inc/Total Assets-0.47Total Liab/Inv Cap0.52
Net Inc/Inv Cap-0.57Total Liab/Comm Equity0.16
Pretax Inc/Net Sales-2.62Interest Coverage Ratio-15.09
Net Inc/Net Sales-2.71Curr Debt/EquityNA
Cash Flow/Net Sales-1.91LTD/Equity0.45
SG&A/NetSales0.71Total Debt/Equity0.45
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio5.91
Inventory TurnoverNACurrent Ratio5.91
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work Cap0.22Inv/Curr AssetsNA
Net Sales/PP&E4.54  

Income Statement (Millions)

  6/30/2019 3/31/2019 12/31/2018 9/30/2018
Total Revenues(Net Sales) 0.01 0.01 0.01 18.01
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 4.85 4.45 3.50 4.32
Operating Income -16.82 -16.87 -19.11 1.43
Interest Exp 0.76 0.75 0.75 0.74
Pretax Income -17.11 -17.08 -19.41 1.13
Other Income 0.47 0.54 0.45 0.44
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -17.11 -17.08 -19.60 -0.38

Balance Sheet (Millions)

Assets 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Cash & Short Term Investments 68.32 80.12 96.09 79.85
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 72.79 81.69 97.75 85.08
Net Property, Plant & Equipment 11.42 11.71 3.97 4.03
Total Assets 85.23 94.73 103.08 90.35
Liabilities        
Accounts Payable 12.88 13.95 16.50 14.56
Debt in Current Liabilities 4.41 2.20 0.00 0.00
Total Current Liabilities 17.31 16.18 16.53 14.59
Long-Term Debt 22.08 24.14 26.20 26.06
Total Liabilities 48.75 49.87 44.94 42.69
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA 0.00
Common Stock 0.02 0.02 0.02 0.02
Retained Earnings -250.08 -232.97 -215.88 -196.28
Treasury Stock NA NA NA NA
Total Stockholders' Equity 36.49 44.85 58.15 47.67
Total Liabilities and Stockholders' Equity 85.23 94.73 103.08 90.35

Cash Flow Summary (Millions)

Categories 6/30/2019 3/31/2019 12/31/2018 9/30/2018
Net Cash Provided by Operating Activities -18.16 -17.68 -11.94 0.95
Net Cash Provided by Investing Activities -0.41 6.10 0.76 -2.08
Net Cash Provided by Financing Activities 6.47 1.77 28.52 0.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20150.05-23.06--
12/20160.05-33.48--
12/20170.04-38.93-2.66
12/201818.04-48.96-2.44
Growth Rates607.17----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/19988,65436.22




Report Date : 9/10/2019

Powered By Edgar Online © 2019EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.